Amanda Feilding: From Taboo to Treatment: The Coming of Age of Psychedelic Medicine



Learn more and donate: http://www.maps.org/

Amanda Feilding: From Taboo to Treatment – The Evolution of Psychedelic Medicine

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

James Fadiman & Sophia Korb: Microdosing – The Phenomenon, Research Results & Startling Surprises



Learn more and donate: http://www.maps.org/

James Fadiman, PhD, and Sophia Korb, PhD
Microdosing: The Phenomenon, Research Results, and Startling Surprises

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

Franz Vollenweider: 5HT2A Receptor Agonists & Mood Disorders – Mood, Empathy & Social Pain



Learn more and donate: http://www.maps.org/

Franz Vollenweider, MD
Psychedelic 5HT2A Receptor Agonists
Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

Bruno Gomes: Plant or Psychedelic Medicine? Understanding the Ayahuasca & Ibogaine Healing Process



Learn more and donate: http://www.maps.org/

Bruno Gomes, MA
Plant Medicine or Psychedelic Medicine? Understanding the Healing Processes with Ayahuasca and Ibogaine

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico – Thomas Kingsley Brown



http://psychedelicscience.org

Help us caption and translate this video on Amara.org:‪ ‬http://www.amara.org/en/videos/ypBoaytF37qb/info/

Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico

Thomas Kingsley Brown, PhD

This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at ...

Continue Reading →
Page 2 of 3 123
UA-77446339-1